IDT Australia Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
13,171.00
15,703.00
7,573.00
9,295.00
12,892.00
Cost of Goods Sold (COGS) incl. D&A
14,306.00
12,949.00
11,317.00
13,863.00
13,344.00
Gross Income
1,135.00
2,754.00
3,744.00
4,568.00
452.00
SG&A Expense
4,999.00
5,935.00
2,028.00
2,889.00
4,311.00
EBIT
6,134.00
3,181.00
-
7,457.00
4,763.00
Unusual Expense
621.00
-
-
7,622.00
14,144.00
Non Operating Income/Expense
139.00
5.00
9.00
162.00
193.00
Interest Expense
31.00
45.00
44.00
15.00
32.00
Pretax Income
6,583.00
3,209.00
5,779.00
14,846.00
18,575.00
Income Tax
43.00
217.00
1,698.00
343.00
1,596.00
Consolidated Net Income
6,626.00
2,992.00
4,081.00
14,503.00
16,979.00
Net Income
6,626.00
2,992.00
4,081.00
14,503.00
16,979.00
Net Income After Extraordinaries
6,626.00
2,992.00
4,156.00
28,233.00
16,979.00
Net Income Available to Common
6,626.00
2,992.00
4,006.00
14,491.00
16,979.00
EPS (Basic)
0.09
0.02
0.02
0.00
0.07
Basic Shares Outstanding
69,600.80
137,699.00
208,171.40
247,607.10
247,829.70
EPS (Diluted)
0.10
0.02
0.02
0.00
0.07
Diluted Shares Outstanding
69,600.80
137,699.00
208,171.40
247,607.10
247,829.70
EBITDA
3,813.00
914.00
3,655.00
5,294.00
2,138.00
Non-Operating Interest Income
64.00
12.00
28.00
86.00
171.00

About IDT Australia

View Profile
Address
45 Wadhurst Drive
Melbourne Victoria (VIC) 3155
Australia
Employees -
Website http://www.idtaus.com.au
Updated 07/08/2019
IDT Australia Ltd. produces, develops and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company specializes in the post-discovery pharmaceutical life cycle.